Black Rock Inc. Amicus Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 24,371,659 shares of FOLD stock, worth $243 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
24,371,659
Previous 22,849,449
6.66%
Holding current value
$243 Million
Previous $269 Million
10.18%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding FOLD
# of Institutions
313Shares Held
314MCall Options Held
516KPut Options Held
833K-
Vanguard Group Inc Valley Forge, PA28.8MShares$287 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$279 Million7.83% of portfolio
-
Wellington Management Group LLP Boston, MA24MShares$239 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$231 Million3.72% of portfolio
-
William Blair Investment Management, LLC Chicago, IL15.6MShares$155 Million0.43% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.79B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...